SUBSCRIBE
SUBSCRIBE
News   Business

Valeant Pharmaceuticals International Reports 2013 Second Quarter Financial Results

August 7, 2013 | 
1 min read

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAVAL, Quebec , Aug. 7, 2013 /CNW/ -

  • Total Revenue $1.1 billion ; an increase of 41% over the prior year, excluding one-time items in 2012 second quarter

  • Product Sales $1.06 billion ; an increase of 43% over the prior year

    • Hey, check out all the research scientist jobs. Post your resume today!

    Earnings
    Valeant Pharmaceuticals International
    MORE ON THIS TOPIC
    Business
    A Conversation with Peter Marks: Insights into GenScript Biotech Forum 2025
    January 16, 2025
     · 
    1 min read
     · 
    Lori Ellis
    San Francisco, USA - May 20, 2022: historic Cable Car Powell Hyde Line on turntable at Powell Street terminal at Market Street in downtown San Francisco, California CA, USA.
    Pipeline
    JPM25 Day 3: AbbVie, Gilead, GSK and Dyne
    January 16, 2025
     · 
    3 min read
     · 
    Tristan Manalac
    Business
    Dispatches From JPM, Biogen’s Sage Buyout Offer, Pfizer’s Obesity Play, More
    January 15, 2025
     · 
    1 min read
     · 
    Heather McKenzie
    Psychedelic Brain
    People
    Lykos Loses Five Board Directors After FDA Rejection
    January 15, 2025
     · 
    2 min read
     · 
    Tristan Manalac